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syndrome? : A magnetoencephalography study
Won Seok Chang1†, Bong Soo Kim1†, Ji Eun Lee1, Hyun Ho Jung1, Kiwoong Kim2, Hyuk Chan Kwon2,
Yong Ho Lee2 and Jin Woo Chang1,3*Abstract
Background: Traditionally, tinnitus accompanied by hemifacial spasm has been considered a type of hyperactive
neurovascular compression syndrome that is similar to hemifacial spasm alone because of the anatomically close
relationship between the facial nerve and cochlear nerve as well as the hyperactive clinical nature.
Methods: Participants were 29 subjects who presented with hemifacial spasm and neuroradiological evidence of
vascular compression of the cranial (facial/cochlear) nerve. We used magnetoencephalography (MEG) to estimate
the activity of the cochlear nerve in patients with and without tinnitus on the ipsilateral side. We compared the
difference in the latency and the ratio of the equivalent current dipole (ECD) strength between the ipsilateral and
contralateral sides of the spasm and tinnitus.
Results: Cochlear nerve activity in patients with tinnitus was increased with a shorter latency (p = 0.016) and
stronger ECD strength (p = 0.028) compared with patients without tinnitus.
Conclusion: The MEG results from normal-hearing patients who had tinnitus accompanied by hemifacial spasm
suggest that the hyperactivity of the auditory central nervous system may be a crucial pathophysiological factor in
the generation of tinnitus in these patients. The neurovascular compression that causes sensory input from the
pathologic facial nerve activity may contribute to this hyperactivity of the central auditory nervous system.
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Tinnitus is defined as the subjective perception of a
sound in the absence of any physical sound source. Tin-
nitus may be the result of spontaneous and aberrant
neural activity of the auditory system. Approximately
5-15% of the population in western societies experience
chronic tinnitus for more than 6 and up to 12 months
[1]. A wide range of therapies including pharmacological* Correspondence: jchang@yuhs.ac
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treatment of tinnitus symptom. Because tinnitus usually
coincides with various ear disorders, surgical treatment
of chronic tinnitus mainly focuses on ontological sur-
gery. However, some types of tinnitus such as pulsatile
tinnitus, which can be caused by vascular compression
of the auditory nerve, may require different therapeutic
approaches.
Microvascular decompression surgery has been used to
treat tinnitus because neurovascular compression of the
cochlear nerve is assumed to be one of the causes of
tinnitus. And this type of Tinnitus is similar to other
neurovascular compression syndromes, such as hemifacial
spasm (HFS) and trigeminal neuralgia [2-5]. Interestingly,
some patients experience ipsilateral tinnitus accompaniedLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 A magnetic resonance image of a patient with tinnitus accompanied by HFS. Upper row: The source image from a three-
dimensional time-of-flight image. Lower row: A three-dimensional Fourier transformation with constructive interference in the steady-state image.
Arrow: The site of neurovascular compression of the facial and vestibulocochlear nerve complex by a branch from the posterior inferior
cerebellar artery.
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patients with HFS in a study by Ryu et al. [6]. If tinnitus is
accompanied by HFS, the surgical outcome following
microvascular decompression has a relatively high success
rate, especially in cases in which the cochlear nerve is
affected [6,7]. It has been suggested that some forms of
tinnitus may be caused by neurovascular compression in




Age (years) Mean (Range) 48.9 (33–69)




Type of tinnitus Low-pitch pulsatile 6
High-pitch continuous 2
Abbreviations: AICA, anterior inferior cerebellar artery; PICA, posterior inferior
cerebellar artery.The pathophysiology of HFS has been relatively well
studied [10]. However, the pathophysiology of tinnitus is
still controversial, especially if tinnitus is accompanied
by HFS. To investigate the pathophysiology of tinnitus
accompanied by HFS, we used magnetoencephalography
(MEG) to study patients and analyzed the relationship
between the presence of tinnitus and the MEG results.
Methods
Participants
Participants were 29 subjects with HFS with neuro-
radiological evidence of vascular compression of cranial
(facial/auditory) nerve. Inclusion criteria were as follows:
1) patients with unilateral HFS; 2) patients with tinnitus
on the same side as the HFS, if the patient had tinnitus;
3) patients with a hearing level better than 20 dB at
1000 Hz and better than 25 dB at each frequency exam-
ined (250 Hz to 3000 Hz with pure tone audiometry,
as measured by an otorhinolaryngologist); 4) patients
without otologic disorders; 5) patients with differences
in hearing levels between the left and right ear of 5 dB
or less; and 6) patients who could undergo MEG and
magnetic resonance imaging (MRI) procedures. The
diagnosis of HFS was made according to clinical symp-
toms and MRI findings of vascular compression of the
Table 2 Summary of results (N100m latency)
Total Clinical
factors
Auditory stimulation side N100m latency p value
(ms, mean ± S.D.)
Total HFS side 101.3 ± 14.3 0.198†
Control side 99.1 ± 10.0
Tinnitus yes HFS side 92.8 ± 7.9 0.016‡
Control side 97.0 ± 7.1
no HFS side 104.5 ± 15.0
Control side 100.0 ± 10.9
Gender Male HFS side 98.5 ± 9.0 0.546‡
Control side 98.3 ± 7.4
Female HFS side 102.0 ± 15.5
Control side 99.1 ± 10.0
Age (years) ≥50 HFS side 104.5 ± 15.1 0.949‡
Control side 100.0 ± 10.9
<50 HFS side 98.9 ± 7.9
Control side 97.0 ± 7.1
Offender AICA HFS side 95.7 ± 9.0 0.333‡
Control side 97.3 ± 7.8
PICA HFS side 107.3 ± 16.7
Control side 101.0 ± 11.8
† N100m latency of HFS side vs. N100m latency of control side, paired t-test.
‡ Comparison of N100m difference according to each factor, Mann–Whitney test.
* Latency of N100m on the HFS side − latency of N100m on the control side.
Abbreviations: AICA, anterior inferior cerebellar artery; PICA, posterior inferior cerebellar artery; S.D., standard deviation.
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December 2011, 29 patients met these criteria and
underwent MEG.
This study was approved by the Korean Food and
Drug Administration. All participants provided written
informed consent, and the study was approved by the
Institutional Review Board of Severance Hospital, Seoul,
Korea (IRB no. 1-2011-0088).
Stimulation and MEG measurement
Tone bursts of 100-ms duration (10-ms slope) were
employed for the acoustic stimulation protocol. Pure
tones of 1000 Hz were applied to the patient’s left and
right ear. The acoustic stimulation consisted of 100
epochs of a random inter-stimulus interval between 900
and 1000 ms. Individual hearing thresholds were deter-
mined before the stimulation. Tones were delivered at a
comfortable level 40 dB above threshold through two
2.5-m long silicon tubes (ER-30, Etymotic Research, Inc.,
USA). Sound stimuli were generated with a STIM2
system (Compumedics Neuroscan, USA).
MEG data for all patients were recorded with a whole-
head MEG system (KRISS, Daejeon, Korea) with 152axial first-order gradiometers. Sound-triggered epochs
(including a 100-ms pre-stimulus baseline) were filtered
online with a bandpass of 0.1-100 Hz and recorded at a
sampling rate of 1000 Hz.
The measured auditory evoked field (AEF) waveforms
were filtered offline with 3–40 Hz band-pass filtering,
and the neuromagnetic responses to the auditory stimuli
were averaged to improve the signal-to-noise ratio. The
baseline for the waveforms was defined as a mean ampli-
tude between −100 and 0 ms relative to the tone onset.
We selected neuromagnetic data in the hemisphere
contralateral to the stimulus to calculate equivalent
current dipoles (ECDs) [5]. The dipolar moment at the
N100m response was used to detect the peak latency of
the N100m and to explain the magnetic field patterns
during the N100m (70–140 ms). The goodness-of-fit (%)
of the N100m dipole was calculated and merged with
the patient’s MRI to verify the anatomical location of the
N100m dipole. To compare the effect of each clinical
factor on the N100m latency and ECD strength, the la-
tency difference of the N100m (the latency of the
N100m on the tinnitus side − the latency of the N100m
on the control side) and the ratio of the ECD strength of
Table 3 Summary of results (ECD strength)
Total Clinical
factors
Auditory stimulation side ECD strength p value
(nAm, mean ± S.D.)
Total HFS side 27.5 ± 9.4 0.265†
Control side 24.8 ± 11.6
Tinnitus yes HFS side 30.5 ± 12.7 0.028‡
Control side 18.8 ± 5.1
no HFS side 26.4 ± 8.0
Control side 27.1 ± 12.6
Gender Male HFS side 27.6 ± 9.3 0.694‡
Control side 25.6 ± 10.4
Female HFS side 27.5 ± 10.2
Control side 24.6 ± 12.1
Age (years) ≥50 HFS side 30.31 ± 1.0 0.234‡
Control side 29.3 ± 12.4
<50 HFS side 24.6 ± 6.5
Control side 20.0 ± 9.6
Offender AICA HFS side 26.5 ± 10.5 0.201‡
Control side 22.0 ± 12.4
PICA HFS side 28.7 ± 8.4
Control side 27.9 ± 10.2
† ECD strength of HFS side vs. ECD strength of control side, paired t-test.
‡ Comparison of the ratio of ECD strength according to each factor, Mann–Whitney test.
* ECD strength of N100m on the HFS side/ECD strength of N100m on the control side.
Abbreviations: AICA, anterior inferior cerebellar artery; ECD, equivalent current dipole; PICA, posterior inferior cerebellar artery; S.D., standard deviation.
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nitus side/the ECD strength of the N100m on the con-
trol side) were calculated.
Clinical data and MEG data were analyzed together.
To compare the N100m latency and ECD strength, the
latency difference of the N100m and the ratio of ECD
strength of the N100m were analyzed by paired t-test
and non-parametric Mann–Whitney tests. All statistical
tests were performed using SPSS v.18.0 (NCSS statistical
software, Kaysville, UT, USA). All statistical tests were
two-tailed. The threshold for statistical significance was
set at p < 0.05.
Results
The 29 patients included 6 males and 23 females with a
mean age of 48.9 years (range, 33–69 years). The most
frequent offending vessels were the anterior inferior
cerebellar artery, followed by the posterior inferior cere-
bellar artery (Figure 1). Among all patients, only eight
patients had ipsilateral tinnitus, which was low-pitch
pulsatile in six patients and high-pitch continuous in
two patients (Table 1). After microvascular decompres-
sion, the HFS of all of the patients with tinnitus was
completely resolved. Furthermore, the tinnitus of seven
of the eight patients with tinnitus disappeared aftersurgery. One patient with high-pitch continuous tinnitus
continued to suffer from tinnitus after surgery.
There were no statistical differences in the N100m la-
tency and ECD strengths between the results of the AEF
waveform on the control side and the AEF waveform on
the HFS side across all patients. The mean N100m
latencies of the control and HFS sides across all patients
were 99.1 ± 10.0 ms (mean ± s.d.) and 101.3 ± 14.3 ms,
respectively (paired t-test, p = 0.198) (Table 2). The mean
ECD strengths of the control and HFS sides across all
patients were 24.8 ± 11.6 nAm and 27.5 ± 9.4 nAm, re-
spectively (paired t-test, p = 0.265) (Table 3). However,
the latency difference in the N100m between the control
side and the HFS side was smaller in patients with tinnitus
compared with patients without tinnitus (−4.1 ± 6.5 with
tinnitus vs. 4.6 ± 8.6 without tinnitus, Mann–Whitney test,
p = 0.016). One interpretation of this result is that the
N100m latencies on the HFS side in patients with tin-
nitus were much shorter than the N100m latencies on
the control side. This result was not evident in patients
without tinnitus (Figures 2 and 3). The ratio of the
ECD strength was greater in patients with tinnitus
compared with patients without tinnitus (1.7 ± 0.6 with
tinnitus vs. 1.1 ± 0.4 without tinnitus, Mann–Whitney
test, p = 0.028) (Figures 1 and 3). However, the latency
Figure 2 A comparison of the difference in the N100m latency
and the ratio of equivalent current dipole strength (ECDs) of
N100m between the control side and HFS side.
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strength of the N100m were not significantly different
according to gender, age, or offending vessel.
Discussion
The concept of a hyperactive neurovascular compres-
sion syndrome such as HFS and trigeminal neuralgia
has been accepted since Dandy’s first report, and
microvascular decompression for these syndromes has
acceptable surgical outcomes [11-14]. Due to the ana-
tomically close relationship between the cochlear
nerve and the facial nerve, some attempts have been
made to perform microvascular decompression to treat
tinnitus, based on the assumption that tinnitus is a
type of hyperactive neurovascular compression syn-
drome. However, the response rate of microvascular
decompression for tinnitus varies from 40 to 77%, and
the tinnitus-free rate is lower than the response rate
[2-5]. In contrast, an interesting report about tinnitus
accompanied by HFS has been published. Ryu et al. in-
vestigated the results of microvascular decompressionfor tinnitus accompanied by HFS. Tinnitus in 7 of 10
(70%) patients was completely resolved after surgery,
which is comparable to the surgical result for HFS and
trigeminal neuralgia [6]. This unexpectedly high suc-
cess rate may be related to the differences in clinical
characteristics of patients with HFS in whom offending
vessels run very close to the cochlear nerve. However,
neurovascular compression has been evident on MRI
in tinnitus patients without HFS in other reports.
Therefore, the pathophysiologic mechanism of tinnitus
accompanied by HFS may be different from the patho-
physiological mechanism of tinnitus alone.
Initially, we assumed that the pathophysiological
mechanism of tinnitus accompanied by HFS might be
quite similar to the two suggested pathophysiological
mechanisms of hyperactive neurovascular compression
syndrome, ephaptic transmission and hyperactive
cranial nerve nucleus and/or higher brain structure. If
tinnitus accompanied by HFS is caused by ephaptic
transmission of the cochlear nerve, then MEG for
these patients should have shown decreased auditory
cortical activity and a delayed latency from the audi-
tory stimulus and cortical evoked field. However, MEG
results of the AEF waveform for our patients with
tinnitus accompanied by HFS showed simultaneously
increased auditory cortical activity and decreased
N100m latency on the HFS side compared with pa-
tients with HFS without tinnitus (Tables 2 and 3). This
result suggests that tinnitus accompanied by HFS is
unlikely to be caused by ephaptic transmission of the
cochlear nerve by neurovascular compression. Therefore,
hyperactivity and hyper-conductivity of the central audi-
tory nervous system may play a key role in the
pathophysiological mechanism [10].
A recent study was published about normal-hearing
patients with tinnitus. In this study, the authors ob-
served a shortening of the I-V latency and enlarged Na
and Pa amplitudes, and concluded that the cause of
tinnitus in these patients seemed to have originated
from the central nervous system [15]. Although the
patients in that study did not have HFS, the tinnitus
conditions were similar to our patients. The results of
our study suggest that tinnitus may originate in the
central nervous system, rather than the cranial nerve
or the root entry zone.
Although the pathophysiology of tinnitus is still con-
troversial, an interesting theory regarding the patho-
physiological mechanism of tinnitus has been introduced
recently. According to the theory, the dorsal cochlear nu-
cleus in the pons, which is modulated by multi-sensory
input, is a strong candidate for the origin of tinnitus
[16-18]. Multi-sensory input can affect dorsal cochlear
nucleus granule cells, leading to changes in dorsal coch-
lear nucleus principal cells [19]. Thus, sensory stimuli
Figure 3 An example of the average dipoles after auditory stimulation (A and B). The ECDs of the N100m, and the N100m latency of a
patient with tinnitus accompanied by left-side HFS are greater and faster after auditory stimulation on the HFS side (A). However, these findings
were not observed in patients without tinnitus (B).
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tinnitus. Further support for the relationship between
sensory stimuli and tinnitus is found in patients with tin-
nitus who are treated with botulinum toxin. Abnormal
movement in the head and neck area can be associated
with tinnitus, and this type of tinnitus is successfully
cured with botulinum toxin injections into the affected
muscle [20,21].
According to our MEG results and recent theories,
hyperactivity of the dorsal cochlear nucleus may be one
of the major pathophysiological mechanisms of tinnitus
accompanied by HFS. In our series, one of eight tin-
nitus patients, who had high-pitch continuous tinnitus
accompanied by HFS, continued to suffer from tinnitus
even though there was no evidence of facial spasm
after microvascular decompression. These results are
comparable with previous outcome reports in which 2
out of 10 patients continued to experience tinnitus
after successful microvascular decompression for HFS,
although some of these patients experienced a decrease
in hearing ability prior to surgery [6]. An irreversible
change in the central auditory nervous system may be
attributable to the symptoms of these patients, and fur-
ther study might be helpful in understanding this
change.Hyperactivity of the central auditory nervous system
should also be considered in the pathophysiological mech-
anism of tinnitus accompanied by HFS. Hyperactivity of
the dorsal cochlear nucleus may be induced by both
neurovascular compression of the cochlear nerve and
multi-sensory input from facial sensory stimuli. In our
study, we could not conclude which factor had more
influence on this hyperactivity. A further clinical trial,
which involves controlling facial sensory input with
botulinum toxic injections instead of microvascular
decompression, will be used to determine the cause of
central auditory hyperactivity.Conclusions
The pathophysiologic mechanism of tinnitus accompan-
ied by HFS in normal-hearing patients is still controver-
sial. From our MEG data, we conclude that the origin of
tinnitus in patients with HFS may not be the cranial
nerve but the central auditory nervous system. Further
investigation and clinical correlation are required to ob-
tain more information.
Abbreviations
AEF: Auditory evoked field; ECD: Equivalent current dipole; HFS: Hemifacial
spasm; MEG: Magnetoencephalography; MRI: Magnetic resonance imaging.
Chang et al. BMC Neurology 2013, 13:42 Page 7 of 7
http://www.biomedcentral.com/1471-2377/13/42Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
WSC organized the research project and wrote the first draft of the
manuscript; BSK performed the research project and reviewed the
manuscript; HHJ organized the research project and reviewed the
manuscript; JEL reviewed and critiqued the revised manuscript; KWK, HCK,
and YHL conceived and organized the research project; JWC conceived the
research project and reviewed and critiqued the manuscript. All authors read
and approved the final manuscript.
Acknowledgements
This work was supported by the Korea Research Council of Fundamental
Science and Technology (KRCF) through a Basic Research Project managed
by the Korea Research Institute of Standards and Science (KRISS).
Author details
1Department of Neurosurgery, Brain Research Institute, Yonsei University
College of Medicine, Seoul, Korea. 2Korea Research Institute of Standard and
Science (KRISS), Daejeon, Korea. 3Department of Neurosurgery, Brain Research
Institute, Yonsei University College of Medicine, 134 Shinchon-Dong,
Seodaemoon-Gu, 120-752, Seoul, Korea.
Received: 19 December 2012 Accepted: 3 May 2013
Published: 8 May 2013
References
1. Crummer RW, Hassan GA: Diagnostic approach to tinnitus. Am Fam
Physician 2004, 69:120–126.
2. Møller MB, Møller AR, Jannetta PJ, Jho HD: Vascular decompression
surgery for severe tinnitus: selection criteria and results. Laryngoscope
1993, 103(4):421–427.
3. Brookes GB: Vascular-decompression surgery for severe tinnitus. Am J
Otol 1996, 17(4):569–576.
4. Vasama J, Moller MB, Moller AR: Microvascular decompression of the
cochlear nerve in patients with severe tinnitus. Preoperative findings
and operative outcome in 22 patients. Neurol Res 1998, 20(3):242–248.
5. Guevara N, Deveze A, Buza V, Laffont B, Magnan J: Microvascular
decompression of cochlear nerve for tinnitus incapacity: pre-surgical
data, surgical analyses and long-term follow-up of 15 patients. Eur Arch
Otorhinolaryngol 2008, 265(4):397–401.
6. Ryu H, Yamamoto S, Sugiyama K, Uemura K, Nozue M: Neurovascular
decompression of the eighth cranial nerve in patients with hemifacial
spasm and incidental tinnitus: an alternative way to study tinnitus.
J Neurosurg 1998, 88(2):232–236.
7. Ryu H, Yamamoto S, Sugiyama K, Nozue M: Neurovascular compression
syndrome of the eighth cranial nerve. What are the most reliable
diagnostic signs? Acta Neurochir (Wien) 1998, 140(12):1279–1286.
8. De Ridder D, Menovsky T, Van de Heyning P: An otoneurosurgical
approach to non-pulsatile and pulsatile tinnitus. B-ENT 2007,
3(Suppl 7):79–86.
9. De Ridder D, Vanneste S, Adriaensens I, Lee A, Van de Heyning P, Moller AR:
Vascular compression of the cochlear nerve and tinnitus: a
pathophysiological investigation. Acta Neurochir (Wien) 2012,
154(5):807–813.
10. Møller A: The cranial nerve vascular compression syndrome: II. A review
of pathophysiology. Acta Neurochir (Wien) 1991, 113(1):24–30.
11. Dandy WE: Concerning the cause of trigeminal neuralgia. Am J Surg 1934,
24(2):447–455.
12. Haines SJ, Jannetta PJ, Zorub DS: Microvascular relations of the trigeminal
nerve. J Neurosurg 1980, 52(3):381–386.
13. Barker FG, Jannetta PJ, Bissonette DJ, Shields PT, Larkins MV, Jho HD:
Microvascular decompression for hemifacial spasm. J Neurosurg 1995,
82(2):201–210.
14. Barker FG, Jannetta PJ, Bissonette DJ, Larkins MV, Jho HD: The long-term
outcome of microvascular decompression for trigeminal neuralgia. N Eng
J Med 1996, 334(17):1077–1084.
15. Singh S, Munjal S, Panda N: Comparison of auditory electrophysiological
responses in normal-hearing patients with and without tinnitus.
J Laryngol Otol 2011, 125(7):668–672.16. Shore S, Koehler S, Oldakowski M, Hughes L, Syed S: Dorsal cochlear
nucleus responses to somatosensory stimulation are enhanced after
noise‐induced hearing loss. Eur J Neurosci 2008, 27(1):155–168.
17. Dehmel S, Pradhan S, Koehler S, Bledsoe S, Shore S: Noise Overexposure
Alters Long-Term Somatosensory-Auditory Processing in the Dorsal
Cochlear Nucleus—Possible Basis for Tinnitus-Related Hyperactivity?
J Neurosci 2012, 32(5):1660–1671.
18. Wang H, Brozoski TJ, Caspary DM: Inhibitory neurotransmission in animal
models of tinnitus: maladaptive plasticity. Hear Res 2011, 279:111–117.
19. Pilati N, Ison MJ, Barker M, Mulheran M, Large CH, Forsythe ID, Matthias J,
Hamann M: Mechanisms contributing to central excitability changes
during hearing loss. Proc Natl Acad Sci 2012, 109(21):8292–8297.
20. Scolozzi P, Carrera E, Jaques B, Kuntzer T: Successful treatment of a
postpolio tinnitus with type a botulinum toxin. Laryngoscope 2005,
115(7):1288–1290.
21. Stidham KR, Solomon PH, Roberson JB: Evaluation of botulinum toxin A in
treatment of tinnitus. Otolaryngol Head Neck Surg 2005, 132(6):883–889.
doi:10.1186/1471-2377-13-42
Cite this article as: Chang et al.: 'Is tinnitus accompanied by hemifacial
spasm in normal-hearing patients also a type of hyperactive
neurovascular compression syndrome? : A magnetoencephalography
study. BMC Neurology 2013 13:42.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
